abstract |
The invention relates to compounds of formula (I) (see formula I) that are inhibitors of activated thrombin activated fibrinolysis. The compounds of the formula I are suitable for the manufacture of medicaments for the prophylaxis, secondary prevention and therapy of one or more disorders associated with thrombosis, embolisms, hypercoagulability or fibrotic changes. |